Home · Stock · TXG

TXG 10X Genomics Inc

Which ETFs hold TXG? 10X Genomics Inc is held by 2 funds tracked by ETFpeek.

Held by 2 funds todayData as of 9 Oct 2026
HealthcareMedical Devices
$77.28
+573.8% 1y
$11.1652-week range$102.81
Market cap
$12.2B
3-month
+80.9%
CEO
Dr. Serge Saxonov Ph.D.
Revenue · last 4 qtrs (-12.7% YoY)

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Provider

Currently Held By

ARK
ARKG
ARK Genomic Revolution ETF
Weight in fund9.23%
Shares held2,446,807
Market value$189.1M
View fund →
ARK
ARKK
ARK Innovation ETF
Weight in fund2.72%
Shares held2,417,076
Market value$186.8M
View fund →
Not held by the selected provider.
last 90 days
Net flow (90d):−$7.6M (1 without value)·0 BUY / 21 SELL·score ≥ 40
DatePersonActionPlanSharesValueScore i
22 Sep 2026
Serge Saxonov
Co-Founder, CEO & Director
SELLUnknown19,200
2 tranches
$1.6M50
24 Aug 2026
Serge Saxonov
Co-Founder, CEO & Director
SELLUnknown18,545$1.2M90
24 Aug 2026
Adam Taich
CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
SELLUnknown17,166$1.1M90
24 Aug 2026
Benjamin J. Hindson
Co-Founder, President, Chief Scientific Officer & Director
SELLUnknown13,818$871K80
11 Aug 2026
John R Stuelpnagel
Director / Other
SELLUnknown17,000$979K60
Net flow (90d):−$7.6M (1 without value)·0 BUY / 21 SELL·showing all trades
DatePersonActionPlanSharesValueScore i
22 Sep 2026
Serge Saxonov
Co-Founder, CEO & Director
SELLUnknown25,000
5 tranches
$2.0M50
22 Sep 2026
Shehnaaz Suliman
Director / Other
SELLUnknown5,723
5 tranches
$465K0
26 Aug 2026
Serge Saxonov
Co-Founder, CEO & Director
SELLUnknown10,486
3 tranches
$668K30
24 Aug 2026
Serge Saxonov
Co-Founder, CEO & Director
SELLUnknown18,545$1.2M90
24 Aug 2026
Adam Taich
CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
SELLUnknown17,166$1.1M90
24 Aug 2026
Benjamin J. Hindson
Co-Founder, President, Chief Scientific Officer & Director
SELLUnknown13,818$871K80
24 Aug 2026
Shehnaaz Suliman
Director / Other
SELLUnknown2,207
2 tranches
$140K30
20 Aug 2026
Serge Saxonov
Co-Founder, CEO & Director
SELLUnknown4,000—30
11 Aug 2026
John R Stuelpnagel
Director / Other
SELLUnknown20,000
2 tranches
$1.2M60
Data: Finnhub (SEC Form 4 filings) · Score: ETFpeek heuristic
42 trades
DateFundDirectionShares Changed% Δ ETF i% Δ Position i
9 Oct 2026ARKKSELLReduced-236,960-0.23%8.93%
7 Oct 2026ARKGSELLReduced-13,680-1.06%0.54%
6 Oct 2026ARKGSELLReduced-27,287-0.15%1.06%
30 Sep 2026ARKKSELLReduced-386,270-0.39%11.22%
30 Sep 2026ARKGSELLReduced-49,178-0.12%1.96%
23 Sep 2026ARKGSELLReduced-49,650-0.12%1.85%
22 Sep 2026ARKGSELLReduced-32,279+0.12%1.21%
15 Sep 2026ARKKSELLReduced-51,475+0.01%1.70%
15 Sep 2026ARKGSELLReduced-271,252-1.05%9.65%
14 Sep 2026ARKKSELLReduced-60,558+0.03%1.96%
9 Sep 2026ARKGSELLReduced-46,404+0.35%1.56%
1 Sep 2026ARKGSELLReduced-49,811+0.06%1.61%
21 Aug 2026ARKKSELLReduced-65,922+0.03%2.08%
20 Aug 2026ARKKSELLReduced-108,680+0.08%3.31%
20 Aug 2026ARKGSELLReduced-94,559-0.14%3.14%
19 Aug 2026ARKKSELLReduced-19,961-0.06%0.61%
19 Aug 2026ARKGSELLReduced-16,523-0.32%0.56%
18 Aug 2026ARKKSELLReduced-52,594+0.04%1.55%
18 Aug 2026ARKGSELLReduced-42,372+0.09%1.41%
14 Aug 2026ARKKSELLReduced-49,449-0.08%1.44%
13 Aug 2026ARKKSELLReduced-21,497-0.09%0.62%
12 Aug 2026ARKKSELLReduced-19,974-0.02%0.57%
11 Aug 2026ARKKSELLReduced-106,996+0.23%2.95%
11 Aug 2026ARKGSELLReduced-15,588+0.82%0.52%
5 Aug 2026ARKKSELLReduced-24,441-0.09%0.66%
4 Aug 2026ARKKSELLReduced-251,093-0.32%6.45%
3 Aug 2026ARKKSELLReduced-77,054-0.13%1.94%
31 Jul 2026ARKKSELLReduced-23,818+0.12%0.59%
29 Jul 2026ARKKSELLReduced-95,988-0.07%2.36%
24 Jul 2026ARKKSELLReduced-152,605+0.05%3.60%
21 Jul 2026ARKKSELLReduced-27,148-0.04%0.63%
20 Jul 2026ARKKSELLReduced-111,018-0.07%2.52%
16 Jul 2026ARKKSELLReduced-99,983-0.07%2.14%
15 Jul 2026ARKKSELLReduced-153,219+0.21%3.17%
14 Jul 2026ARKKSELLReduced-55,834-0.15%1.11%
13 Jul 2026ARKKSELLReduced-158,299-0.02%2.41%
10 Jul 2026ARKKSELLReduced-156,645+0.30%2.95%
1 Jul 2026ARKKSELLReduced-390,937-0.20%7.11%
16 Jun 2026ARKKSELLReduced-535,174-0.16%7.90%
12 Jun 2026ARKKSELLReduced-259,251-0.14%3.12%
11 Jun 2026ARKKSELLReduced-43,181-0.07%0.61%
4 Jun 2026ARKKSELLReduced-218,343+0.12%3.10%
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

More stocks in these funds